Related Experiment Videos
Lipoprotein and apoprotein values in coronary angiography patients
Insights
This study found that higher levels of LDL cholesterol and apolipoprotein B (apo B) are linked to coronary artery disease (CAD). Apo B effectively distinguishes between patients with and without CAD, highlighting its importance in cardiovascular risk assessment.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
- Biochemistry
Background:
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- Lipoprotein and apoprotein profiles are crucial indicators of cardiovascular risk.
- Understanding these profiles in CAD patients can improve diagnostic and therapeutic strategies.
Purpose of the Study:
- To evaluate lipoprotein and apoprotein patterns in men with varying degrees of coronary artery disease.
- To identify key biomarkers differentiating CAD patients from healthy controls.
- To assess the correlation between specific lipid and apoprotein levels and the severity of coronary atherosclerosis.
Main Methods:
- Coronary arteriography was performed on 179 male patients.
- Patients were categorized into a control group (normal arteriogram) and three CAD severity groups (scores 1-3).
- Plasma concentrations of total cholesterol, LDL cholesterol, triglycerides, HDL cholesterol, apolipoprotein A-I (apo A-I), apolipoprotein A-II (apo A-II), and apolipoprotein B (apo B) were measured and analyzed using discriminant function analysis.
Main Results:
- CAD patients exhibited significantly higher total cholesterol, LDL cholesterol, triglycerides, and apo B levels compared to controls.
- HDL cholesterol and apo A-I levels were significantly lower in CAD patients.
- Apo B and LDL cholesterol levels showed a positive correlation with the severity of coronary atherosclerosis.
- Apo B was identified as the most effective parameter for discriminating between control and CAD patients.
Conclusions:
- Elevated apo B and LDL cholesterol are significant indicators of coronary artery disease.
- Apo B is a potent biomarker for differentiating individuals with and without CAD.
- Lipoprotein and apoprotein profiling, particularly apo B measurement, can aid in assessing cardiovascular risk and disease severity.
Abstract:
In this study the lipoprotein and apoprotein patterns of patients with coronary artery disease were evaluated. The patient population consisted of 179 men who underwent coronary arteriography. On the basis of the results of coronary arteriography these patients were subdivided into a control group (score 0) with normal arteriograms and three groups each having coronary artery disease (CAD) of increasing severity (scores 1 to 3). The patients with coronary artery disease had significantly higher plasma concentrations of total cholesterol, LDL cholesterol, triglycerides and apolipoprotein B (apo B) than the controls. HDL cholesterol as well as apolipoprotein A-I (apo A-I) were significantly lower in patients with coronary artery disease. However, no difference was found in apolipoprotein A-II (apo A-II) values. Apo B and LDL cholesterol increased with the degree of coronary atherosclerosis. In the discriminant function analysis, apo B was the best separating parameter between control patients and CAD patients (scores 1-3).